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Abstract
Regulation of cellular functions during dermal repair following injury is complex and critically dependent on the
interaction of cells with the surrounding extracellular matrix (ECM). The ECM comprises various families of macro-
molecules that form the structural scaffold of the tissue, but also carry distinct biological activities. After injury to
the skin, the defect is filled by a provisional matrix that is invaded by inflammatory cells, sprouting blood vessels
and fibroblasts. In a later phase, the wound contracts, the tissue is replaced by mature connective tissue produced
by activated fibroblasts, and a scar is formed. All cells involved communicate directly with the ECM by integrins
and other matrix receptors. These transmit signals and induce adaptive responses to the environment by the
embedded cells. The ECM or proteolytic fragments of individual ECM constituents exert defined biological activities
influencing cell survival, differentiation of myofibroblasts, ECM synthesis and turnover, wound angiogenesis and
scar remodeling. Extensive crosstalk exists between ECM and growth factors, and between growth factors and
integrins. ECM-cell contact also enables direct transmission of mechanical tension, which then modulates many
activities of all cellular players. Understanding this complex interplay is important to provide a basis for designing
effective wound therapy and for strategic interference with mechanisms that have gone out of control in fibrotic
conditions.
Review
The functioning of cells is critically dependent on their
interaction with the surrounding extracellular matrix
(ECM) [1]. These cells include not only fibroblasts,
osteoblasts and chondrocytes but also endothelial,
inflammatory, epithelial and smooth muscle cells. The
direct interaction of these cells with the ECM is
mediated by specific cellular receptors, which bind the
ECM components, but they can also involve other cell
surface glycoproteins that indirectly mediate the contact
with structural components of the ECM. Cell-ECM
interactions further enable the transmission of mechani-
cal forces, which are generated in all tissues. The cellu-
lar activities controlled by this interaction are required
for normal development, but they are also crucially
involved in several physiological and pathological pro-
cesses, in particular wound healing, scarring and fibrosis.
In this review, the individual players orchestrating the
cellular response after tissue injury to the skin are
discussed.
The extracellular matrix
Research over the past 20 years has increased our
understanding of the composition of the ECM struc-
tures, and identified and characterized distinct families
of matrix proteins (Appendix 1). These protein families
include several subfamilies of collagenous proteins,
adhesive glycoproteins, proteoglycans and matricellular
proteins. A common denominator is their composition
from a limited number of structural domains. It is
important to note that these individual domains carry
biological activities, modulate the activity of growth fac-
tors and cytokines, and harbor recognition sites for the
interaction with specific cell membrane receptors [2,3].
ECM proteins form the structural scaffold of all tissues.
They interact closely with each other, thereby construct-
ing large networks with structural and non-structural
components. In addition, th e yh a v em a n ym o r es p e c i a -
lized functions that regulate cellular behavior either by
direct cell-ECM interaction or by the modulation of
growth factor activities [4]. Synthesis, deposition and
remodeling of ECM proteins are essential for the
restoration of damaged tissue during the early and late
phases of wound healing.
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Collagens
Collagens represent a group of diverse protein subfa-
milies containing at least 28 different collagen types
that are encoded by more than 42 genes [3,5]. All
members share a common structural feature, the pre-
sence of at least one triple helical domain. Their struc-
tural organization and supramolecular assembly
depends on the specific subfamily of collagens, thus
the interstitial collagens aggregate into fibrils, collagen
VI aggregates into microfibrillar structures, collagen IV
and VIII build large networks, and collagen VII forms
the anchoring fibrils in the skin. Further subfamilies
include fibril-associated collagens with interrupted tri-
ple helices, multiplexins (multiple triple helical
domains and interruptions) and transmembrane col-
lagens (Appendix 2). Multiplexins carry glycosamino-
glycan chains and are thus considered not only as
collagens, but also as proteoglycans. The transmem-
brane collagens contribute to the formation of cell-
ECM contact sites such as hemidesmosomes and focal
adhesions. They can be proteolytically shed from the
cell surface, and the shed forms are detectable in the
ECM and in body fluids. Processing is not unique to
transmembrane collagens as many of the other large
ECM molecules such as multiplexins are also proteoly-
tically modified. Cleavage generates fragments that
carry new biological activities, several of which regulate
angiogenesis directly or indirectly, for example, by
modulating integrin binding [6].
Endostatin, a fragment of collagen XVIII, is one of the
best-characterized collagen fragments [7]. It is an inhibi-
tor of angiogenesis and has been intensively investigated
as an anti-angiogenic peptide in tumor models [8]. Find-
ings about its role in dermal wound healing are contro-
versial. The anti-angiogenic proteolytic fragments of
collagen IV, tumstatin and canstatin have been also stu-
died in wound healing, but no effect was noted [9]. For
the more recently identified collagen XV fragment, res-
tin, no wound healing data are yet available [10]. By
contrast, endorepellin, the C-terminal fragment of perle-
can, is a powerful inhibitor of angiogenesis by inducing
actin disassembly and focal adhesion disruption in
endothelial cells [6]. The anti-angiogenic activity of
endorepellin is based on its binding to integrin a2b1,
followed by activation of the phosphatase SHP-1 (Src
homology 2 domain phosphatase-1), which then depho-
sphorylates, thus inactivating receptor tyrosine kinases
including vascular endothelial growth factor (VEGF)
receptors [11].
Elastin
Together with other large glycoproteins, such as, fibrillin
and fibulin, elastin is a component of the elastic tissue.
It is present in the dermis and several other connective
tissues such as vessel walls. Several diseases are linked
to mutations in components of the elastic tissue, includ-
ing some forms of cutis laxa or Marfan syndrome [12].
Elastic fibers are not detected in the granulation tissue
synthesized during early phases of wound healing, indi-
cating that a certain differentiated status of fibroblasts is
required to produce elastic tissue [13].
Proteoglycans
Proteoglycans are composed of positively charged poly-
saccharide chains attached to a protein backbone. They
can be very large and are hydrophilic, which endows
them with high water-binding capacity, and confers vis-
coelasticity and compression resistance to tissues. Pro-
teoglycans are found in basement membranes, on cells
and in matrices surrounding mesenchymal cells. Perle-
can, a heparan sulfate proteoglycan, has (in addition to
its structural role) a number of signaling functions via
its heparan sulfate chains, which bind and modulate
growth factors such as fibroblast growth factor (FGF)2,
VEGF and platelet-derived growth factor [14]. The
importance of heparan sulfate chains in growth factor
regulation has been shown in perlecan heparan sulfate
deficient-mice, which display delayed wound healing
and poor vascularization of wound tissue due to reduced
FGF2-mediated angiogenesis [15]. Further, overexpres-
sion of recombinant heparanase improves wound heal-
i n gb yi n c r e a s i n gm a t u r ea-smooth muscle actin-
positive blood vessels and by accelerating wound closure
and epithelialization. The proposed mechanism is mobi-
lization of heparan-bound growth factors from the ECM
[16]. Interestingly, degradation products of hyaluronan,
which is a large, unsulfated glycosaminoglycan without
an associated protein core, led to an increase in the
number of blood vessels [17].
Fibronectin
One of the best-characterized glycoproteins of the ECM
is fibronectin, a major product of dermal fibroblasts and
myofibroblasts, which has a wide distribution in the der-
mis, in the dermal-epidermal basement membrane zone.
Fibronectin is a large adhesive glycoprotein with a huge
number of different functions. Besides its structural role,
fibronectin is the main cell adhesion molecule, modulat-
ing many cellular activities. In humans, alternative spli-
cing generates close to 20 fibronectin variants with
different functions, of which the ED-A variant is an
important regulator of fibroblast to myofibroblast differ-
entiation [18]. After injury, fibronectin is initially depos-
ited from blood plasma, and plays an important role in
platelet function with the release of growth factors and
cytokines [19]. Together with fibrin it provides most of
the provisional matrix in dermal wounds, guiding fibro-
blasts and inflammatory cells to the site of injury. In
restoring a neodermis, fibroblasts secrete fibronectin
dimers, which are organized into a dense pericellular
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ion [20]. The formation of a stable collagen I/III fibrillar
network is thought to depend on a pre-existing fibro-
nectin network through a mechanism involving integrins
a2b1 and a11b1 [21,22].
Laminins
Laminins represent a protein family of 16 currently
known members. Laminins are large trimeric ECM gly-
coproteins consisting of three different polypeptide
chains [23]. Laminin chains self-polymerize and interact
with other basement membrane proteins such as col-
lagen IV, perlecan and nidogen. They are the major con-
stituents of the dermoepidermal basement membrane
and that of blood vessels. Laminins control cell migra-
tion, differentiation and proliferation. In skin repair,
laminins are key molecules regulating re-epithelialization
and vascularization. Laminins 411 and 511 are the major
isofoms in the basement membranes of blood vessels.
They are produced by human dermal microvascular
endothelial cells and pericytes [24].
Matricellular proteins
More recently a group of proteins named the matricellu-
lar proteins was identified. These proteins interact with
other structural ECM molecules and cell surface recep-
tors, and modulate cytokine activation. They are thought
to function as important regulatory molecules rather
than as structural components [25].
The multi-domain protein thrombospondin represents
a family of five members, of which thrombospondin-2 is
the predominant member; it is expressed by fibroblasts
and endothelial cells in murine skin. Thrombospondin-1
is found in platelets and is secreted by inflammatory
cells [26,27]. Thrombospondin-1 and -2 have been
ascribed anti-angiogenic activities [28]. Both forms are
specifically expressed at different phases during tissue
repair, thrombospondin-1 in the early and thrombos-
pondin-2 in the late phases. In early wound stages,
thrombospondin-1 act as a chemoattractant for macro-
phages [29], and modulates transforming growth factor
(TGF)-b activation and signaling. As a likely result,
wounds in thrombospondin-1 null mice heal at lower
rates. In mice overexpressing thrombospondin-1 in skin,
wound healing is delayed, and associated with dimin-
ished angiogenesis and reduced granulation tissue for-
mation [30]. In thrombospondin-2 null mice, wound
healing is accelerated and the microvascular network is
increased [27]. These observations indicate that the
functions of thrombospondin-1 and -2 in skin are dic-
tated primarily by their spatiotemporal expression pat-
terns. Less information is available on the role of the
other thrombospondin family members. However,
despite distinct, non-redundant roles in specific tissues,
they all support cell attachment and binding to other
ECM proteins [31].
The secreted acidic and cysteine-rich protein family
includes SPARC (secreted protein acidic and rich in
cysteine, also known as osteonectin and BM40) and
hevin, both expressed in skin, primarily by fibroblasts
[32]. In vitro, both proteins exhibit de-adhesive and
anti-migratory activities. Wound closure is accelerated
in both SPARC and hevin null mice [33,34]. However,
in hevin null mice, accelerated wound closure was in
part attributed to its de-adhesive and anti-migratory
function for dermal fibroblasts [34], whereas in SPARC
null mice, acceleration was attributed to decreased col-
lagen content rendering the skin more susceptible to
cell contraction [33].
The matricellular family of tenascin proteins com-
prises four members in mammals. Tenascins are large
glycoproteins with structural similarity to fibronectin.
Like SPARC and thrombospondin-1, they do not sup-
port cell adhesion. Tenascin-C is abundantly present in
the provisional wound matrix, and its synthesis by fibro-
blasts is strongly enhanced by mechanical tension [35].
Skin wounds of tenascin-C null mice display diminished
fibronectin but close normally [36]. Tenascin-X is far
less abundant than tenascin-C in skin. Patients deficient
in tenascin-X have a rare variant of Ehlers-Danlos syn-
drome, with skin hyperextensibility [37]. Although
patient skin is characterized by reduced density of col-
lagen fibers and abnormal elastin fibers [38], scars are
not atrophic but tend to be wider than normal, and scar
tissue in tenascin-X null mice has reduced stability [39].
The extracellular matrix and growth factors
Many ECM constituents actively modify the activity of
growth factors and cytokines and some act as a reservoir
from which growth factors can be rapidly released if
required (Table 1). The ECM can also protect growth
factors from degradation [40,41].
Probably the best example is the binding of FGF-2 to
the heparan sulfate proteoglycan, perlecan. This binding
promotes FGF receptor activation and ultimately down-
stream signaling, which supports mitogenesis and angio-
genesis [42]. Other examples are the inactivation of
TGF-b by binding to decorin [43], and the activation of
TGF-b by binding to thrombospondin-1 [44]. VEGF
Table 1 Growth factors binding to the extracellular
matrix
basic fibroblast growth factor
(FGF-2)
heparan sulfate proteoglycan
transforming growth factor b
(TGF-b)
decorin, thrombospondin-1
vascular endothelial growth factor
(VEGF)
heparan sulfate proteoglycan
platelet derived growth factor
(PDGF)
heparan sulfate proteoglycan
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within various ECM molecules, and release of VEGF by
plasmin or heparanase triggers endothelial cell prolifera-
tion [45]. Further enhanced endothelial cell proliferation
is achieved by VEGF binding to the heparin II domain
in fibronectin if the same fibronectin molecule is bound
to the endothelial cell via integrin a5b1. This example
highlights a novel mechanism implicating the ECM in
bringing a signaling integrin receptor and a growth fac-
tor receptor in close apposition to facilitate angiogenesis
[46].
These modifications in the availability and activity of
growth factors and cytokines by defined constituents of
the ECM contribute to the versatile response of cells to
a changing environment. This interaction is most
obvious in situations in which large amounts of active
cytokines are required, such as in wound healing and
tissue remodeling. However, ECM modulation is equally
important in situations when cellular activities must be
turned down to reduce tissue damage and scarring, as
in late stages of tissue repair or after inflammatory
processes.
Within the past few years, a new class of ligands, the
matrikines and matricryptins, has been characterized as
subdomains of various ECM proteins, which can signal
to cells through receptors such as growth factor recep-
tors [47]. The EGF-like repeats in tenascin-C and lami-
nin are examples of matrikines. At these sites they bind
to EGF receptors, thereby enhancing cell motility
[47,48]. In the case of laminin 332, this activity appears
to occur only after cleavage by matrix metalloprotei-
nases (MMPs) [49]. During wound healing, tenascin-C
and laminin 332 are expressed by keratinocytes at the
leading edge, correlating temporally with keratinocyte
migration and MMP-2 expression. Based on this, bind-
ing of the released laminin fragment to the epidermal
growth factor receptor (EGFR) is believed to provide
pro-migratory tracks within the edges of the healing
wound for migrating and proliferating keratinocytes,
whereas binding of tenascin-C may enhance migration
and de-adhesion of cells [4,50]. Decorin, which acts as a
suppressor of cellular proliferation, is another EGFR
binding matrikine. Binding results in decreased EGFR
levels and suppression of EGFR autophosphorylation
[51]. Hence, during wound repair, matrikine signaling
from decorin could function as a quiescence signal eli-
citing decreased migration, proliferation and ECM
synthesis by fibroblasts after the wound has reached a
mature state [50].
In summary, the individual domains of the ECM can
interfere with growth factor signaling either by direct
interaction with growth factor receptors or indirectly by
controlling the availability and activity of growth factors
and cytokines. This versatility of ECM components in
regulating cellular activities is further expanded by close
cooperation between growth factor signaling and integ-
rin-mediated cell-matrix interactions and mechanical
tension (discussed in detail below).
Integrins and cell-matrix interactions
Although many receptors for ECM proteins have been
identified, the integrin family probably constitutes the
most abundant receptors mediating the interaction of
cells with their surrounding ECM. Integrins have a rela-
tively restricted, cell type-specific and context-dependent
expression with defined substrate specificity. Ligands
bind to the extracellular domains of integrins, and integ-
rin cytoplasmic tails connect via linker proteins to the
cytoskeleton. Integrins mediate cell adhesion, migration
and survival, and also specific differentiation programs
relevant to development, tissue maintenance and repair.
By virtue of linking the outside environment with the
cellular inside, they transduce signals and mechanical
tension bidirectionally from the outside in and the
inside out [52,53].
Integrin function is closely connected with integrin
conformation [54]. Usually, integrins are expressed at
the cell surface in an inactive form. Signals arising from
the cytoskeleton (inside-out signaling) modulate integrin
conformation. Talin and kindlin were recently described
as key linker proteins responsible for integrin activation
[55,56]. Activation results in increased affinity for ECM
molecules and clustering into focal adhesions [57,58]
with rapid tyrosine phosphorylation of specific sub-
strates and an increase in the concentration of lipid sec-
ond messengers. This is then followed by cytoskeletal
rearrangements, modulation of Rho GTPase activity,
and reorganization of actin binding proteins, affecting
virtually all cellular functions [59] (Figure 1).
Integrin expression and activity can be further modu-
lated by other transmembrane proteins such as tetraspa-
nins or cell surface heparan sulfate proteoglycans. Most
of these are expressed in a cell type-specific manner in
different phases of skin repair and scarring [60].
Activation of integrins, transmission of mechanical
tension originating from tissue remodeling, and the
regulated activity of growth factors play crucial roles in
controlling cellular activities during dermal repair, scar-
ring and fibrosis. Activation of TGF-b by av integrins is
a good example of such interplay. Binding of latent
TGF-b to integrin avb6, which is abundantly expressed
by keratinocytes in wound epithelium and in chronic
wounds [61], induces a conformational change in the
latent complex, resulting in unmasking of the mature
TGF-b moiety, presentation to TGF-b receptors on
adjacent cells, and induction of TGF-b signaling in a
strictly locally confined manner [62,63]. By contrast,
integrin agb8 binding to the same site in the latent
Eckes et al. Fibrogenesis & Tissue Repair 2010, 3:4
http://www.fibrogenesis.com/content/3/1/4
Page 4 of 11TGF-b complex is independent of cell-cell contact and
instead presents the latent complex to membrane-bound
MMPs that reside in close vicinity to the integrin in the
same cell. Proteolytic activation of the latent complex
releases freely diffusible mature TGF-b that is active at
distant sites [64].
Angiogenesis can be controlled by the crosstalk
between avb3 and FGF that results in modulation of
FGF signaling [65,66], and by the stable interaction
between integrin a5b1 and Tie-2 tyrosine kinase recep-
tor that regulates endothelial cell response to angiopoie-
tin-1 [67].
T h em e c h a n i s m sb yw h i c hi n t e g r i n sm o d i f yc e l l u l a r
responses to growth factors can involve direct regulation
of transcriptional programs, complex activation mechan-
isms or various signaling cascades. The data available
also clearly demonstrate a close link between the ECM,
the cytoskeleton and growth factor/cytokine release, and
the cellular response. Obviously, most experiments have
been based on monolayer culture systems, and only lim-
ited information is available on how cells interact with
the ECM in a complex three-dimensional system such
as the dermis. In those situations, the cellular architec-
ture is modified and mechanical tension is generated,
which modulates integrin functions and the cellular
response to growth factors.
Regulation of fibroblast activation
Although there is increasing evidence that in certain
specialized tissues, epithelial cells participate in fibrosis
and scarring, in most tissues fibroblasts are the main
effector cells for the production and deposition of new
and sometimes excessive ECM. Fibroblasts were among
the first cells grown in culture dishes, but specific mar-
kers are still lacking and their differentiation is only
incompletely understood. They are generally defined by
their morphology and by a characteristic pattern of gene
expression. In tissue repair, they synthesize most ECM
Figure 1 Integrin signaling. Activated integrins bind to extracellular matirix (ECM)ligands and signal via phosphorylation of intracellular linker
proteins or lipid second messengers and small GTPases, eliciting reorganization of the cytoskeleton, changes in gene expression and modulation
of many cellular responses. AKT, protein kinase B; ERK, extracellular signal-regulated kinase; JNK, Jun N-terminal kinase, PIP3, phosphatidyl inositol
triphosphate.
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deling in later phases. Fibroblasts also secrete numerous
growth factors and cytokines that act on other cell types
thereby modulating tissue repair and scarring [68,69].
After tissue damage and the initial inflammatory reac-
tion, fibroblasts are modulated from quiescent cells to
migratory, proliferating and biosynthetically active cells.
It is well established that they can be transformed into
myofibroblasts, the contractile activated cell type, which
is mainly responsible for scar contraction and excessive
ECM deposition [68]. The finely tuned balance between
the activated and quiescent fibroblast subpopulations
seems to determine scar quality.
Origin of fibroblasts in wounds, scars and fibrosis
The exact origin of fibroblasts in wounds or fibrotic tis-
sue remains unclear and is still a matter of debate. A
certain fraction of fibroblasts within wounds and scars
originates from resident cell populations. In normal
wounds, the balance between growth factor activity and
the integration of fibroblasts into an environment with
stable mechanical tension ensures cell survival and gene
expression patterns required for normal tissue remodel-
ing [70]. Changes in mechanical stiffness and in release
of growth factors from inflammatory cells can be the
initial stimulus for the activation of resident tissue fibro-
blasts, with formation of contractile actin stress fibers
and firm attachment via fibroblast integrins to the ECM
[71,72].
Many studies have considered alternative origins of
fibroblasts in scarring and fibrosis. A significant percen-
tage of fibroblasts in dermal wounds was derived from
bone marrow in green fluorescent protein transgenic
mice [73]. There is also evidence that bone marrow-
derived cells contribute to the disease process in certain
fibrotic diseases [74]. However, it is not clear whether or
how these cells are related to circulating fibrocytes, the
leukocyte subpopulation characterized by collagen pro-
duction and surface markers indicative of hematopoietic
origin, which have been described to contribute to
wound healing and fibrosis [75,76].
Although this field is rapidly developing, the specific
roles of these different fibroblast progenitor populations
are incompletely understood. It is likely that the extent
of matrix deposition and tissue destruction in wounds
or inflamed tissue depends on the local environment,
ECM composition, magnitude of integrin-mediated
mechanical stress, and growth factors released by differ-
ent populations of circulating progenitors (Figure 2).
Myofibroblast formation
Myofibroblasts have long been associated with wound
repair and fibrosis [77]. They are contractile cells, which
are thought to develop from fibroblasts after specific
external stimuli or from circulating mesenchymal pre-
cursor cells (see previous section). The prime function
of myofibroblasts is reconstruction of granulation tissue
by producing new ECM, and contraction and remodel-
ing of wound and scar tissue. Myofibroblasts are key
effectors in hypertrophic scars and have recently also
been implicated in fibrotic processes, for example, in
scleroderma.
Previously, myofibroblasts were characterized ultra-
structurally by electron microscopy. They differ from
normal fibroblasts by the expression of a-SMA, which is
the most widely used marker for myofibroblasts. They
are also characterized by expression of the ED-A splice
variant of fibronectin and the upregulated synthesis of
several ECM proteins and growth factors [78]. Induction
of ED-A fibronectin, in turn, requires presence of TGF-
b together with mechanical tension, indicating that com-
plex paracrine and autocrine networks are involved in
regulating myofibroblast formation in wound healing
[70,78]. In addition, keratinocyte-fibroblast interactions
in coculture systems have been reported to lead to myo-
fibroblast formation. In this system, TGF-b together
with endothelin-1 have been identified as responsible
factors [79].
Figure 2 Formation of myofibroblasts and their effects on extracellular matrix (ECM) homeostasis. Myofibroblasts may arise from various
cellular sources. Their differentiation and activity are modulated by the surrounding ECM, growth factor activity and mechanical tension.
Myofibroblasts affect connective tissue homeostasis by upregulated production of ECM proteins, fibrogenic mediators and protease inhibitors.
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by establishing cell-cell and cell- ECM contacts and
tractional forces. They form bundles of contractile
microfilaments and extensive cell matrix contacts, which
attach the microfilamentst ot h es u r r o u n d i n gE C M .
These contacts (the so-called fibronexi) have been
defined ultrastructurally [80]. Formation of supermature
focal adhesion structures and establishment of the a-
SMA-rich network of stress fibers are hallmarks of myo-
fibroblasts. They provide an integrin-based system for
the transduction of mechanical forces between these
cells and the surrounding ECM [72,81].
In the later stages of normal wound repair, myofibro-
blasts undergo apoptosis and disappear. Loss of mechan-
ical tension, alterations in cell density or protease
activity and/or changes in the pattern of secreted growth
factors are thought to contribute to cell death. Under-
standing the exact cellular and molecular basis for clear-
ance of myofibroblasts is essential because in
pathological situations (e.g. scarring or fibrosis), myofi-
broblasts persist and are responsible for some of the
clinical symptoms.
Other cell types involved in ECM deposition in scar
formation and fibrosis
Many other cell types either directly or indirectly contri-
bute to scar formation. The early inflammatory infiltrate
is initially activating a complex cascade of factors, which
depend on one another and profoundly influence late
events after most of the inflammatory cells have
disappeared.
In certain tissues, epithelial-mesenchymal transition
plays an important role during development, but has
more recently also attracted attention for explaining the
development of fibrosis, for example, in kidney and pos-
sibly in lung. In response to growth factors and altered
ECM contacts, epithelial cells can lose their epithelial
polarity and adopt a mesenchymal phenotype [69].
The microvascular pericytes are integral parts of all
microvessels, and play an important role in regulating
endothelial cells. Although the precise function of peri-
cytes is not clear they crucially contribute to stabilize
and mediate forces within the microvasculature [82].
Pericytes contain contractile proteins and can probably
generate contractile forces. In fibrosis and dermal repair,
pericytes become activated, and may represent a pool of
mesenchymal precursor cells in the tissue.
The role of mechanical tension
All adherent cells including endothelial cells, fibroblasts
and myofibroblasts sense tension originating from the
environment. Tension is transmitted via cell-ECM con-
tacts [83], leading to reorganization of the cytoskeleton
and the elicitation of specific signals that modulate gene
expression. In muscles, bone, tendon, skin and vessels,
alterations of mechanical forces are continuously recog-
nized by cells and their functions are adapted according
to the biological requirements. If mechanical tension is
removed, those tissues undergo atrophy, indicating the
important role of mechanical signals for maintaining
proper functioning of the organism [84].
Obviously, fibroblasts and myofibroblasts are cells
implicated in scarring, which is strongly influenced by
mechanical tension. Both cell types firmly attach to
ECM structures via matrix adhesions, which have been
studied in detail in monolayer cultures (see previous
sections). These include the focal complexes, focal adhe-
sions and fibrillar adhesions. The major structures
required to form such matrix contacts are the integrin
receptors, which directly connect the ECM structures to
the intracellular cytoskeleton network [85]. Fibroblasts
and myofibroblasts in the skin use a5b1o rav integrins
to bind to fibronectin, whereas collagens are primarily
recognized by integrins a1b1, a2b1a n da11b1a n dt oa
lesser extent by other receptors such as cell surface
heparan sulfate proteoglycans (syndecans) or discoidin
domain receptors (Table 2). Mechanical forces act on
focal adhesions, resulting in further structural matura-
tion [72,86].
More recently, fibroblasts have been grown in three-
dimensional ECM structures, in which cell shape is
modified and they become bipolar. A clear distinction of
the different attachment sites is more difficult, but these
structures are equally important and establish a direct
connection between the surrounding ECM and the cell
nucleus [87,88]. Using collagens as three-dimensional
structures, several groups have demonstrated that apply-
ing tension to the matrix directly affects the biosynthetic
capacities of fibroblasts [89].
Table 2 Collagen receptors
Integrin receptors recognizing fibrillar collagens
collagen I a1b1, a2b1, a11b1
collagen II a10b1
collagen III a1b1, a2b1, a11b1
collagen V a1b1, a2b1
collagen I fibrils a2b1, a11b1
denatured collagen I avb
Non integrin collagen receptors
discoidin domain receptor-1 and -2 (DDR1,
DDR2)
glycoprotein VI (GPVI)
leukocyte-associated immunoglobulin-like
(LIAR-1)
syndecans
glypicans
CD44
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The precise mechanisms by which different cell types
transmit mechanical signals are not fully understood.
They might involve stretch-activated ion channels, direct
interactions between structural and signaling compo-
nents, or activation of small GTPases [90].
As outlined above, many cooperative interactions exist
between integrins and growth factor signaling. In parti-
cular, fibroblast to myofibroblast conversion and a-SMA
expression crucially depend on a combination of
mechanical tension and TGF-b [81]. Thus in scarring,
generation of tension can induce myofibroblast forma-
tion, causing a self-perpetuating loop. A similar auto-
crine loop is discussed for the induction of collagen
synthesis in fibroblasts by mechanical tension. In this
case, TGF-b is induced by tension, which in turn acti-
vates collagen synthesis via the classic pathways [91]. In
addition, fibronectin is induced by the application of
cyclic strain to fibroblasts. In parallel, many proteases
are downregulated, whereas protease inhibitors are upre-
gulated. Extensive work has concentrated on tenascin-C,
which is found in tissues with high tensile stress [35].
Detailed analysis using several in vitro systems has
demonstrated that tenascin-C expression is strongly
upregulated at the transcriptional level by mechanical
stress, involving specific cis-acting elements in the tenas-
cin-C promoter [92,93].
These data clearly demonstrate that mechanical ten-
sion, which is generated during wound contraction, scar
formation and in fibrotic tissue, can modulate the gene
expression of fibroblasts and myofibroblasts embedded
into this tissue at different molecular levels. Tension
directly modifies gene transcription, induces signaling
from integrins affecting small GTPases or induces/inhi-
bits growth factor signaling, which then indirectly affects
ECM protein synthesis by fibroblasts/myofibroblasts. By
a combination of these mechanisms, mechanical tension
induces an activated, contractile fibroblast/myofibroblast
phenotype characterized by high levels of synthesis of
ECM proteins, low protease activity and high production
of fibrogenic cytokines.
Conclusions and perspectives
Interaction of cells with the surrounding ECM is an
important modulator of all cellular activities (Figure 3).
Tight control is required, particularly to ensure homeo-
static conditions during development, tissue repair and
in fibrotic situations, in which cellular activities are
either turned on or downregulated. Crosstalk with the
surrounding ECM is essential for the function of all
cells, and in the context of scarring and fibrosis it is
probably most crucial for fibroblasts and myofibroblasts.
The interaction of these cells with different ECM con-
stituents is mediated by several integrins that signal
bidirectionally and transmit mechanical forces that are
generated during pathological situations. Cell-ECM
interactions mediated by integrins are closely linked to
growth factor signaling and to complex modulation of
the cellular cytoskeleton. This complex interplay con-
trols the specific gene expression program at any given
Figure 3 Interaction of cells with the extracellular matrix (ECM) during dermal repair. This schematic illustrates different types of cell-ECM
interactions. For details, please refer to the text.
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Page 8 of 11time. Detailed insight into the roles of different ECM
proteins, the function of integrins, their modulation by
forces, and their interplay with growth factors will help
us to understand the orchestration of tissue architecture
and the processes underlying excessive scarring and
fibrosis.
Appendices
Appendix 1: Composition of the extracellular matrix in
skin
￿ Structural proteins: collagens, elastin, fibrillins,
fibulins
￿ Adhesive glycoproteins: fibronectin, vitronectin,
matrilins, laminins
￿ Proteoglycans: perlecan, syndecans, versican, dec-
orin, biglycan, lumican
￿ Matricellular proteins: thrombospondins, tenas-
cins, SPARC/BM-40/osteonectin
Appendix 2: The collagen subfamilies
￿ Fibril-forming collagens (I, II, III)
￿ Fibril-associated collagens with interrupted helices
(IX, XII, XIV, XX, XXI, XVI)
￿ Hexagonal network-forming collagens (VIII)
￿ Basement membrane-associated collagens (IV, VII,
XVII, XVIII)
￿ Beaded-filament forming collagens (VI)
￿ Transmembrane collagens (XIII, XVII, XXIII,
XXV)
￿ Multiplexins (XV, XVIII)
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